← Every applicant
Ani Pharms FDA Approvals
7 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NITAZOXANIDENew drugFeb 3, 2025TABLET, ORAL |
| CARBOPROST TROMETHAMINENew drugJan 25, 2024INJECTABLE, INJECTION |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDENew drugDec 15, 2023CAPSULE, EXTENDED RELEASE, ORAL |
| BACLOFENNew drugJun 8, 2023SUSPENSION, ORAL |
| COLESTIPOL HYDROCHLORIDENew drugMar 10, 2023TABLET, ORAL |
| FESOTERODINE FUMARATENew drugJan 4, 2023TABLET, EXTENDED RELEASE, ORAL |
| LEVOTHYROXINE SODIUMNew drugJan 6, 2021CAPSULE, ORAL |